94 results
Page 3 of 5
8-K
EX-10.3
hb6kef95
15 Jun 21
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor Option to Reduce Future Dilution
4:03pm
8-K
EX-99.1
3skk5t5b
7 May 21
Other Events
4:01pm
8-K
EX-99.1
kewqoq
6 May 21
INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business Update
4:05pm
8-K
EX-1.1
7x80a2n8fg 9wkjn
11 Mar 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
xqaxh
21 Jan 21
Other Events
7:12am
8-K
EX-99.1
5mx4bczg7q8qr4xxqw9
12 Nov 20
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM Modulating an Innate Immune Response Against Diseases IN MB CORPORATE PRESENTATION Nov 2020
12:00am
8-K
EX-99.2
hism61yjn evdy0pckdd
9 Nov 20
Other Events
4:10pm
8-K
EX-99.1
kkix0c
27 Oct 20
Other Events
6:03am
8-K
EX-99.1
ibe53 04rq41uztx64
29 Sep 20
Forward Looking Statements
12:41pm
8-K
EX-99.1
yf21za3bl vg29
3 Sep 20
Other Events
6:02am
8-K
EX-99.1
jzz0ao8wlhnj
7 Aug 20
Other Events
4:05pm
8-K
EX-99.1
tift81xywlf4ipgpjg7
30 Jul 20
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM Modulating an Innate Immune Response Against Diseases IN MB CORPORATE PRESENTATION Aug 2020
9:08am
8-K
EX-1.1
irkaek5
16 Jul 20
INmune Bio, Inc. Prices Public Offering of Common Stock
9:27am
8-K
EX-99.2
oo27dznm 7fxikkj
13 Jul 20
Other Events
4:18pm
8-K
EX-99.1
b7ewf b0g3v7
10 Jul 20
INmune Bio, Inc. to Announce Interim Data from Phase Ib Clinical Study of XPro1595 in Patients with Alzheimer’s Disease Prior to Start of AAIC 2020
4:01pm
8-K
EX-99.1
rek40b6 b7b
18 May 20
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM Modulating an Innate Immune Response Against Diseases IN MB CORPORATE PRESENTATION May 2020
6:21am